David Francis Capes

MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore.

Part of EUDA Health Holdings Ltd., EUDA Health Ltd. is a health technology company based in Singapore, Singapore. The Singaporean company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. EUDA Health's holistic approach supports patients throughout all stages of care, including wellness & prevention, urgent care & emergencies, pre-existing conditions, and aftercare services. EUDA Health Ltd. was founded in 2019 by Wei Wen Chen, who has been the CEO since 2019. EUDA Health was acquired by 8i Acquisition 2 Corp. from Watermark Developments Ltd. on November 17, 2022 for $95.84 million.

Rockeby Biomed Ltd. provides research, development and marketing of rapid testing technologies for infectious diseases in animals and humans. The company's main market is in-vitro diagnostic testing which includes serology testing in hospitals as well as point of care rapid tests for use by healthcare professionals and consumers inside and outside of traditional healthcare environments. The company is headquartered in West Perth, Australia.